1	The	the	DET	DT	_	2	det	_	start_char=0|end_char=3
2	aim	aim	NOUN	NN	_	6	nsubj	_	start_char=4|end_char=7
3	of	of	ADP	IN	_	5	case	_	start_char=8|end_char=10
4	this	this	DET	DT	_	5	det	_	start_char=11|end_char=15
5	study	study	NOUN	NN	_	2	nmod	_	start_char=16|end_char=21
6	was	be	VERB	VBD	_	0	root	_	start_char=22|end_char=25
7	to	to	PART	TO	_	8	mark	_	start_char=26|end_char=28
8	radiolabel	radiolabel	VERB	VB	_	6	xcomp	_	start_char=29|end_char=39
9	Bevacizumab	bevacizumab	NOUN	NN	_	8	obj	_	start_char=40|end_char=51
10	with	with	ADP	IN	_	14	case	_	start_char=52|end_char=56
11	(	(	PUNCT	-LRB-	_	14	punct	_	start_char=57|end_char=58
12	99m	99m	NOUN	NN	_	14	compound	_	start_char=59|end_char=62
13	)	)	PUNCT	-RRB-	_	14	punct	_	start_char=63|end_char=64
14	Tc	tc	NOUN	NN	_	9	nmod	_	start_char=65|end_char=67
15	and	and	CONJ	CC	_	17	cc	_	start_char=68|end_char=71
16	to	to	PART	TO	_	17	mark	_	start_char=72|end_char=74
17	evaluate	evaluate	VERB	VB	_	8	conj	_	start_char=75|end_char=83
18	in	in	X	FW	_	19	compound	_	start_char=84|end_char=86
19	vivo	vivo	X	FW	_	17	advmod	_	start_char=87|end_char=91
20	its	its	PRON	PRP$	_	22	nmod:poss	_	start_char=92|end_char=95
21	imaging	imaging	NOUN	NN	_	22	compound	_	start_char=96|end_char=103
22	properties	property	NOUN	NNS	_	17	obj	_	start_char=104|end_char=114
23	in	in	ADP	IN	_	27	case	_	start_char=115|end_char=117
24	an	a	DET	DT	_	27	det	_	start_char=118|end_char=120
25	adenocarcinoma	adenocarcinoma	NOUN	NN	_	27	compound	_	start_char=121|end_char=135
26	animal	animal	NOUN	NN	_	27	compound	_	start_char=136|end_char=142
27	model	model	NOUN	NN	_	22	nmod	_	start_char=143|end_char=148
28	.	.	PUNCT	.	_	6	punct	_	start_char=149|end_char=150

1	The	the	DET	DT	_	2	det	_	start_char=151|end_char=154
2	aim	aim	NOUN	NN	_	6	nsubj	_	start_char=155|end_char=158
3	of	of	ADP	IN	_	5	case	_	start_char=159|end_char=161
4	this	this	DET	DT	_	5	det	_	start_char=162|end_char=166
5	study	study	NOUN	NN	_	2	nmod	_	start_char=167|end_char=172
6	was	be	VERB	VBD	_	0	root	_	start_char=173|end_char=176
7	to	to	PART	TO	_	8	mark	_	start_char=177|end_char=179
8	radiolabel	radiolabel	VERB	VB	_	6	xcomp	_	start_char=180|end_char=190
9	sorafenib	sorafenib	NOUN	NN	_	8	obj	_	start_char=191|end_char=200
10	(	(	PUNCT	-LRB-	_	11	punct	_	start_char=201|end_char=202
11	1	1	NUM	CD	_	9	appos	_	start_char=203|end_char=204
12	)	)	PUNCT	-RRB-	_	11	punct	_	start_char=205|end_char=206
13	with	with	ADP	IN	_	14	case	_	start_char=207|end_char=211
14	carbon-11	carbon-11	NOUN	NN	_	9	nmod	_	start_char=212|end_char=221
15	and	and	CONJ	CC	_	17	cc	_	start_char=222|end_char=225
16	to	to	PART	TO	_	17	mark	_	start_char=226|end_char=228
17	evaluate	evaluate	VERB	VB	_	8	conj	_	start_char=229|end_char=237
18	its	its	PRON	PRP$	_	19	nmod:poss	_	start_char=238|end_char=241
19	potential	potential	NOUN	NN	_	17	obj	_	start_char=242|end_char=251
20	as	as	ADP	IN	_	22	case	_	start_char=252|end_char=254
21	TKI-PET	tki-pet	NOUN	NN	_	22	compound	_	start_char=255|end_char=262
22	tracer	tracer	NOUN	NN	_	19	nmod	_	start_char=263|end_char=269
23	in	in	X	FW	_	24	compound	_	start_char=270|end_char=272
24	vivo	vivo	X	FW	_	17	advmod	_	start_char=273|end_char=277
25	.	.	PUNCT	.	_	6	punct	_	start_char=278|end_char=279

1	Our	we	PRON	PRP$	_	2	nmod:poss	_	start_char=280|end_char=283
2	goal	goal	NOUN	NN	_	3	nsubj	_	start_char=284|end_char=288
3	was	be	VERB	VBD	_	0	root	_	start_char=289|end_char=292
4	to	to	PART	TO	_	5	mark	_	start_char=293|end_char=295
5	radiolabel	radiolabel	VERB	VB	_	3	xcomp	_	start_char=296|end_char=306
6	an	a	DET	DT	_	7	det	_	start_char=307|end_char=309
7	antibody	antibody	NOUN	NN	_	5	obj	_	start_char=310|end_char=318
8	at	at	ADP	IN	_	10	case	_	start_char=319|end_char=321
9	several	several	ADJ	JJ	_	10	amod	_	start_char=322|end_char=329
10	iodine	iodine	NOUN	NN	_	7	nmod	_	start_char=330|end_char=336
11	:	:	PUNCT	:	_	3	punct	_	start_char=337|end_char=338
12	antibody	antibody	NOUN	NN	_	14	compound	_	start_char=339|end_char=347
13	molar	molar	ADJ	JJ	_	14	amod	_	start_char=348|end_char=353
14	ratios	ratio	NOUN	NNS	_	3	dep	_	start_char=354|end_char=360
15	under	under	ADP	IN	_	16	case	_	start_char=361|end_char=366
16	conditions	condition	NOUN	NNS	_	14	nmod	_	start_char=367|end_char=377
17	protecting	protect	VERB	VBG	_	16	acl	_	start_char=378|end_char=388
18	its	its	PRON	PRP$	_	20	nmod:poss	_	start_char=389|end_char=392
19	combining	combine	VERB	VBG	_	20	amod	_	start_char=393|end_char=402
20	site	site	NOUN	NN	_	17	obj	_	start_char=403|end_char=407
21	and	and	CONJ	CC	_	23	cc	_	start_char=408|end_char=411
22	to	to	PART	TO	_	23	mark	_	start_char=412|end_char=414
23	compare	compare	VERB	VB	_	5	conj	_	start_char=415|end_char=422
24	its	its	PRON	PRP$	_	26	nmod:poss	_	start_char=423|end_char=426
25	immunoreactive	immunoreactive	ADJ	JJ	_	26	amod	_	start_char=427|end_char=441
26	fraction	fraction	NOUN	NN	_	23	obj	_	start_char=442|end_char=450
27	(	(	PUNCT	-LRB-	_	28	punct	_	start_char=451|end_char=452
28	IRF	irf	NOUN	NN	_	26	appos	_	start_char=453|end_char=456
29	)	)	PUNCT	-RRB-	_	28	punct	_	start_char=457|end_char=458
30	and	and	CONJ	CC	_	32	cc	_	start_char=459|end_char=462
31	electrophoretic	electrophoretic	ADJ	JJ	_	32	amod	_	start_char=463|end_char=478
32	mobility	mobility	NOUN	NN	_	26	conj	_	start_char=479|end_char=487
33	with	with	ADP	IN	_	34	case	_	start_char=488|end_char=492
34	those	those	PRON	DT	_	32	nmod	_	start_char=493|end_char=498
35	of	of	ADP	IN	_	38	case	_	start_char=499|end_char=501
36	the	the	DET	DT	_	38	det	_	start_char=502|end_char=505
37	same	same	ADJ	JJ	_	38	amod	_	start_char=506|end_char=510
38	antibody	antibody	NOUN	NN	_	34	nmod	_	start_char=511|end_char=519
39	radiolabeled	radiolabele	VERB	VBN	_	38	acl	_	start_char=520|end_char=532
40	without	without	ADP	IN	_	41	case	_	start_char=533|end_char=540
41	protection	protection	NOUN	NN	_	39	obl	_	start_char=541|end_char=551
42	.	.	PUNCT	.	_	3	punct	_	start_char=552|end_char=553

